Sign in

Filings

Finds words inside filing documents. Searching Petros Pharmaceuticals, Inc.'s filings · 15 documents indexed.

8 documents · 76 matches

  1. PTPI Petros Pharmaceuticals, Inc. 10-Q 2026-08-13

    Item 1A. Risk Factors.

    continue as a going concern. Management has substantial doubt about the Company’s ability to continue as a going concern.
    11 matches in this document
  2. PTPI Petros Pharmaceuticals, Inc. 10-Q 2026-05-13

    Item 1A. Risk Factors.

    continue as a going concern. Management has substantial doubt about the Company’s ability to continue as a going concern.
    12 matches in this document
  3. PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-11-13

    Item 1A. Risk Factors.

    continue as a going concern. Management has substantial doubt about the Company’s ability to continue as a going concern.
    10 matches in this document
  4. PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-08-14

    Item 1A. Risk Factors.

    continue as a going concern. Management has substantial doubt about the Company’s ability to continue as a going concern.
    10 matches in this document
  5. PTPI Petros Pharmaceuticals, Inc. 10-Q 2025-05-15

    Item 1A. Risk Factors.

    continue as a going concern. Management has substantial doubt about the Company’s ability to continue as a going concern.
    12 matches in this document
  6. PTPI Petros Pharmaceuticals, Inc. 10-K 2026-04-15

    Item 1A. Risk Factors

    going concern as we have suffered recurring losses from operations and have insufficient liquidity to fund our future operations. If we are unable
    19 matches in this document
  7. PTPI Petros Pharmaceuticals, Inc. 8-K 2026-09-30

    Item 1.03. Bankruptcy or Receivership

    Company has ceased substantially all of its business operations and no longer has the ability to continue as a going concern.
    1 match in this document
  8. PTPI Petros Pharmaceuticals, Inc. 8-K 2025-06-20

    Item 7.01. Regulation FD Disclosure.

    going concern value, rights and claims (“Assets”) of Metuchen, including Metuchen’s wholly-owned subsidiaries, Timm Medical Technologies, Inc. (“Timm
    1 match in this document

Page 1 of 1 · 8 documents